These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 27153510

  • 21. [Inhaled corticosteroids in patients with COPD: maintain current guidelines].
    Heijdra YF.
    Ned Tijdschr Geneeskd; 2007 Oct 06; 151(40):2195-7. PubMed ID: 17969568
    [Abstract] [Full Text] [Related]

  • 22. Sputum inflammation predicts exacerbations after cessation of inhaled corticosteroids in COPD.
    Liesker JJ, Bathoorn E, Postma DS, Vonk JM, Timens W, Kerstjens HA.
    Respir Med; 2011 Dec 06; 105(12):1853-60. PubMed ID: 21802933
    [Abstract] [Full Text] [Related]

  • 23. The use of long acting β₂-agonists, alone or in combination with inhaled corticosteroids, in chronic obstructive pulmonary disease (COPD): a risk-benefit analysis.
    Cave AC, Hurst MM.
    Pharmacol Ther; 2011 May 06; 130(2):114-43. PubMed ID: 21276815
    [Abstract] [Full Text] [Related]

  • 24. Advances in inhaled corticosteroids for the treatment of chronic obstructive pulmonary disease: what is their value today?
    Cazzola M, Ora J, Calzetta L, Rogliani P, Matera MG.
    Expert Opin Pharmacother; 2022 Jun 06; 23(8):917-927. PubMed ID: 35575510
    [Abstract] [Full Text] [Related]

  • 25. Inhaled corticosteroids can reduce osteoporosis in female patients with COPD.
    Liu SF, Kuo HC, Liu GH, Ho SC, Chang HC, Huang HT, Chen YM, Huang KT, Chen KY, Fang WF, Lin MC.
    Int J Chron Obstruct Pulmon Dis; 2016 Jun 06; 11():1607-14. PubMed ID: 27478374
    [Abstract] [Full Text] [Related]

  • 26. Therapeutic responses in asthma and COPD. Corticosteroids.
    Larj MJ, Bleecker ER.
    Chest; 2004 Aug 06; 126(2 Suppl):138S-149S; discussion 159S-161S. PubMed ID: 15302774
    [Abstract] [Full Text] [Related]

  • 27. [Friend or foe: combination therapy with inhaled corticosteroids and long-acting beta2-agonists in chronic obstructive pulmonary disease (COPD)].
    Gillissen A, Gessner C, Hoheisel G, Juergens U.
    Pneumologie; 2008 Jul 06; 62(7):430-7. PubMed ID: 18398787
    [Abstract] [Full Text] [Related]

  • 28. Inhaled corticosteroids in COPD: the clinical evidence.
    Ernst P, Saad N, Suissa S.
    Eur Respir J; 2015 Feb 06; 45(2):525-37. PubMed ID: 25537556
    [Abstract] [Full Text] [Related]

  • 29. [The effects of inhaled steroids withdrawal in COPD].
    Jebrak G, Honore I, Serrier P, Dumoulin J, Terrioux P, Soyez F, Maurer C, Mangiapan G, Febvre M, Couderc LJ, Braun JM, Chinet T.
    Rev Mal Respir; 2017 Oct 06; 34(8):820-833. PubMed ID: 28506728
    [Abstract] [Full Text] [Related]

  • 30. Disease Burden of Patients with Asthma/COPD Overlap in a US Claims Database: Impact of ICD-9 Coding-based Definitions.
    Wurst KE, St Laurent S, Hinds D, Davis KJ.
    COPD; 2017 Apr 06; 14(2):200-209. PubMed ID: 28103123
    [Abstract] [Full Text] [Related]

  • 31. [Secondary osteoporosis: Inhaled corticosteroids induced osteoporosis in respiratory diseases].
    Ieda Y, Nagasaka Y.
    Clin Calcium; 2007 Jun 06; 17(6):955-62. PubMed ID: 17548937
    [Abstract] [Full Text] [Related]

  • 32. Inhaled corticosteroids in COPD: a controversy.
    Barnes PJ.
    Respiration; 2010 Jun 06; 80(2):89-95. PubMed ID: 20501985
    [Abstract] [Full Text] [Related]

  • 33. Inhaled corticosteroids for chronic obstructive pulmonary disease.
    Park HY, Man SF, Sin DD.
    BMJ; 2012 Oct 25; 345():e6843. PubMed ID: 23100329
    [No Abstract] [Full Text] [Related]

  • 34. Economic assessment of early initiation of inhaled corticosteroids in chronic obstructive pulmonary disease using propensity score matching.
    Akazawa M, Biddle AK, Stearns SC.
    Clin Ther; 2008 Oct 25; 30 Spec No():1003-16. PubMed ID: 18640475
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Pharmacological basis and scientific rationale underlying the targeted use of inhaled corticosteroid/long-acting β2-adrenergic agonist combinations in chronic obstructive pulmonary disease treatment.
    Pelaia G, Muzzio CC, Vatrella A, Maselli R, Magnoni MS, Rizzi A.
    Expert Opin Pharmacother; 2015 Oct 25; 16(13):2009-21. PubMed ID: 26194120
    [Abstract] [Full Text] [Related]

  • 37. Asthma COPD Overlap Syndrome: An Approach to A Real -World Endotype in Obstructive Lung Disease?
    Laucho-Contreras M, de Oca MM, Owen CA.
    Curr Pharm Des; 2016 Oct 25; 22(41):6273-6282. PubMed ID: 27604607
    [Abstract] [Full Text] [Related]

  • 38. Management of chronic obstructive pulmonary disease: moving beyond the asthma algorithm.
    Gordon E, Lazarus SC.
    J Allergy Clin Immunol; 2009 Nov 25; 124(5):873-80; quiz 881-2. PubMed ID: 19895979
    [Abstract] [Full Text] [Related]

  • 39. Benefits and risks of inhaled corticosteroids in chronic obstructive pulmonary disease.
    Bonay M, Bancal C, Crestani B.
    Drug Saf; 2002 Nov 25; 25(1):57-71. PubMed ID: 11820912
    [Abstract] [Full Text] [Related]

  • 40. The asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges.
    Barrecheguren M, Esquinas C, Miravitlles M.
    Curr Opin Pulm Med; 2015 Jan 25; 21(1):74-9. PubMed ID: 25405671
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.